Quarterly report · Q2
7733.TEDINET S100S68V
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥436.6bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥228.9bn | 2023-07-01 → 2023-09-30d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥881.9bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥417.1bn | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥224.8bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥17.7bn | 2023-07-01 → 2023-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥93.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥49.1bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥958m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥20.7bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥182.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥89.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥47.3bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥216.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥24.3bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥143.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥66.8bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥42.0bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥216.7bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Net income | −¥24.0bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥66.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.0bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥1.62T | at 2023-09-30 | Cons. | Assets IFRS |
| Total assets | ¥1.51T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.49T | at 2022-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥790.2bn | at 2023-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥867.1bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥827.5bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥641.2bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥644.1bn | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥511.4bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥827.5bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥640.1bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥643.0bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥488.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥169.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥205.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥297.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | −¥11.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥98.5bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥6.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | ¥412.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥58.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥15.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥125.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥143.2bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥35.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥173.81 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-19.64 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥113.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥52.5 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥32.97 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥173.43 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-19.6 | 2023-07-01 → 2023-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥113.08 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥52.45 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥32.93 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 51.2% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 42.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.3% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 10
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥18.6bn |
| jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥50.9bn |
| jpcrp040300-q2r_E02272-000Otherreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥28.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥23.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥4.3bn |
| jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥68.9bn |
| jpcrp040300-q2r_E02272-000Otherreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥788m |
| jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥29.8bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥97.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 781
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in trade and other payables ope cf IFRS | Prior1YTDDuration | -4918000000 | JPY |
| Increase decrease in trade and other payables ope cf IFRS | CurrentYTDDuration | -12717000000 | JPY |
| Increase decrease in retirement benefit liability ope cf IFRS | Prior1YTDDuration | -672000000 | JPY |
| Increase decrease in retirement benefit liability ope cf IFRS | CurrentYTDDuration | -104000000 | JPY |
| Decrease increase in retirement benefit asset ope cf IFRS | Prior1YTDDuration | 940000000 | JPY |
| Decrease increase in retirement benefit asset ope cf IFRS | CurrentYTDDuration | -426000000 | JPY |
| Increase decrease in provisions ope cf IFRS | Prior1YTDDuration | -3038000000 | JPY |
| Increase decrease in provisions ope cf IFRS | CurrentYTDDuration | 5248000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YTDDuration | -17412000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYTDDuration | 15312000000 | JPY |
| Subtotal ope cf IFRS | Prior1YTDDuration | 65245000000 | JPY |
| Subtotal ope cf IFRS | CurrentYTDDuration | 80138000000 | JPY |
| Interest received ope cf IFRS | Prior1YTDDuration | 1478000000 | JPY |
| Interest received ope cf IFRS | CurrentYTDDuration | 1127000000 | JPY |
| Dividends received ope cf IFRS | Prior1YTDDuration | 30000000 | JPY |
| Dividends received ope cf IFRS | CurrentYTDDuration | 3000000 | JPY |
| Interest paid ope cf IFRS | Prior1YTDDuration | -2659000000 | JPY |
| Interest paid ope cf IFRS | CurrentYTDDuration | -2475000000 | JPY |
| Income taxes refund paid ope cf IFRS | Prior1YTDDuration | -57787000000 | JPY |
| Income taxes refund paid ope cf IFRS | CurrentYTDDuration | -90570000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YTDDuration | 6307000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYTDDuration | -11777000000 | JPY |
| Payments into time deposits inv cf IFRS | Prior1YTDDuration | -2137000000 | JPY |
| Payments into time deposits inv cf IFRS | CurrentYTDDuration | － | JPY |
| Purchase of property plant and equipment inv cf IFRS | Prior1YTDDuration | -20387000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | CurrentYTDDuration | -21449000000 | JPY |
| Proceeds from sale of property plant and equipment inv cf IFRS | Prior1YTDDuration | 19514000000 | JPY |
| Proceeds from sale of property plant and equipment inv cf IFRS | CurrentYTDDuration | 974000000 | JPY |
| Purchase of intangible assets inv cf IFRS | Prior1YTDDuration | -9804000000 | JPY |
| Purchase of intangible assets inv cf IFRS | CurrentYTDDuration | -7330000000 | JPY |
| Purchase of investment securities inv cf IFRS | Prior1YTDDuration | -3517000000 | JPY |
| Purchase of investment securities inv cf IFRS | CurrentYTDDuration | -15000000 | JPY |
| Proceeds from sale of ssd businessse inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from sale of ssd businessse inv cf IFRS | CurrentYTDDuration | 381898000000 | JPY |
| Proceeds from transfer of collagen business and dental product sales businesses inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from transfer of collagen business and dental product sales businesses inv cf IFRS | CurrentYTDDuration | 1656000000 | JPY |
| Proceeds from sale of subsidiaries inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from sale of subsidiaries inv cf IFRS | CurrentYTDDuration | 4375000000 | JPY |
| Collection of loans receivable inv cf IFRS | Prior1YTDDuration | 476000000 | JPY |
| Collection of loans receivable inv cf IFRS | CurrentYTDDuration | 52637000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | 202000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | -45000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -15653000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | 412701000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | Prior1YTDDuration | -122000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | CurrentYTDDuration | -3000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -9543000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -10166000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -17822000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -20057000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |